Cargando…
m(6)A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer
Objective: Increasing evidence highlights the roles of N(6)-methyladenosine (m(6)A) and its regulators in oncogenesis. Herein, this study observed the associations of m(6)A regulators with breast cancer. Methods: RNA-seq profiles of breast cancer were retrieved from the Cancer Genome Atlas (TCGA) da...
Autores principales: | Hu, Ying, Pan, Qinwen, Wang, Minghao, Ai, Xiang, Yan, Yuzhao, Tian, Yuan, Jing, Yuting, Tang, Peng, Jiang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380833/ https://www.ncbi.nlm.nih.gov/pubmed/34434939 http://dx.doi.org/10.3389/fmed.2021.667543 |
Ejemplares similares
-
YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation
por: Ye, Jing, et al.
Publicado: (2020) -
Fragment
Ligands of the m(6)A-RNA
Reader YTHDF2
por: Nai, Francesco, et al.
Publicado: (2022) -
m(6)A facilitates YTHDF‐independent phase separation
por: Liu, Si‐Yu, et al.
Publicado: (2019) -
m(6)A binding protein YTHDF2 in cancer
por: Chen, Xiaomin, et al.
Publicado: (2022) -
The biological function of m6A reader YTHDF2 and its role in human disease
por: Wang, Jin-yan, et al.
Publicado: (2021)